跳至主要内容
临床试验/JPRN-UMIN000015727
JPRN-UMIN000015727已完成未知

Randomized, controlled trial of the clinical effect of selecrive SGLT2 blocker, ipragliflozin, and DPP-4 blocker in type 2 diabetic patients with NAFLD/NASH.- multicenter study - - Randomized, controlled trial of ipragliflozin and DPP-4 blocker in type 2 diabetic patients with NAFLD/NASH.

Saga University0 个研究点目标入组 55 人开始时间: 2014年11月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Ppatients with diabetes 2.Patients with past history of ovascular lesion or stroke 3.Patients with past history of allergy 4.Patients with the necessity of IRI therapy 5.Patients with past history of liver disorder or renal dysfunction 6.Inadequacy of usingig this therapy

研究者

相似试验

Randomized, controlled trial of the clinical effect... | 临床试验